For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi® System, a ...

BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

John Phillips, M.D., FACS John Phillips, M.D., FACS, has been named chair of the Department of Urology at New York ...

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate.

It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...

Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment ...

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.